drugset / Trial / NCT01206647
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
Phase 4
Unknown
120 enrolled
ikfe-CRO GmbH
AstraZeneca · collabIKFE Institute for Clinical Research and Development · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the success rate of a switch from insulin therapy to a metformin \& saxagliptin combination in patients with type 2 diabetes mellitus.
Timeline
- Start
- 2010-02
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 2000 mg | Oral |
| Subject | SAXAGLIPTIN ANHYDROUS | Small molecule | 5 mg | Oral |